• MAIA reports positive efficacy results from Phase II trial for NSCLC Clinical Trials Arena Thu, 09 Jul 2026 10:44:19 GMT
• Data released by MAIA Biotechnology Inc. show that the combination therapy of its candidate drug Apatganosin with Ximiprilizumab d... Bitget Thu, 09 Jul 2026 06:47:16 GMT
• Maia Biotechnology Reports Initial Efficacy Data from Phase 2 Thio-101 Part C Expansion Trial in Third-Line Non-Small Cell Lung Ca... marketscreener.com Wed, 08 Jul 2026 17:20:45 GMT
• MAIA Biotechnology Reports 90.5% Interim Disease Control Rate in Phase 2 THIO-101 Part C for Advanced NSCLC Quiver Quantitative Wed, 08 Jul 2026 13:50:00 GMT
• data released by maia biotechnology inc. show that the combination therapy of its candidate drug apatganosin with ximiprilizumab d... Bitget Wed, 08 Jul 2026 05:56:14 GMT
• Enterprise value to EBITDA forward of MAIA Biotechnology, Inc. – AMEX:MAIA TradingView Mon, 06 Jul 2026 12:30:48 GMT
• Price to earnings forward of MAIA Biotechnology, Inc. – BOATS:MAIA TradingView Mon, 06 Jul 2026 06:17:18 GMT
• MAIA Biotechnology (MAIA) director receives grant of 26,982 stock options Stock Titan Thu, 02 Jul 2026 20:17:15 GMT
• MAIA Biotechnology (MAIA) director awarded 26,355 stock options at $1.44 Stock Titan Thu, 02 Jul 2026 20:14:43 GMT
• MAIA Biotechnology (NASDAQ: MAIA) director granted 27,610 stock options at $1.44 strike Stock Titan Thu, 02 Jul 2026 20:12:13 GMT
• Director at MAIA Biotechnology (MAIA) receives 32,003 stock options grant Stock Titan Thu, 02 Jul 2026 20:11:21 GMT
• MAIA Biotechnology (NASDAQ: MAIA) director receives 32,630 stock options grant Stock Titan Thu, 02 Jul 2026 07:00:00 GMT
• 26,355 stock options granted to MAIA (NASDAQ: MAIA) director Jean-Manasse Stock Titan Thu, 02 Jul 2026 07:00:00 GMT
• MAIA Biotechnology, Inc. Actuals & Estimates (AMEX:MAIA) TradingView Fri, 26 Jun 2026 23:50:39 GMT
• maia biotechnology, inc. actuals & estimates (boats:maia) TradingView Fri, 26 Jun 2026 23:36:50 GMT
• Why Is MAIA Biotechnology (NYSE:MAIA) Tracking Higher on Trial News? Kalkine Media Fri, 26 Jun 2026 18:24:00 GMT
• MAIA finishes THIO-101 enrollment abroad, with 41 lung cancer patients treated Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• maia biotechnology completes international enrollment in part c of phase 2 thio-101 expansion trial in third-line non-small cell l... The Manila Times Thu, 25 Jun 2026 07:00:00 GMT
• Noble Financial Maintains MAIA Biotechnology(MAIA.US) With Buy Rating, Maintains Target Price $14 富途牛牛 Mon, 22 Jun 2026 07:00:00 GMT
• MAIA activates new site for THIO-101 Phase II trial Clinical Trials Arena Fri, 19 Jun 2026 07:00:00 GMT
• maia biotechnology opens third clinical site in u.s. for phase 2 thio-101 trial TipRanks Thu, 18 Jun 2026 23:26:43 GMT
• Maia Biotechnology Inc (MAIA) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Thu, 18 Jun 2026 22:31:34 GMT
• MAIA Biotechnology Opens Enrollment for Phase 2 Expansion GlobeNewswire Thu, 18 Jun 2026 07:00:00 GMT
• maia biotechnology inc (maia) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 06:56:22 GMT
• maia biotechnology inc (maia) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 06:23:11 GMT
• maia biotechnology inc (maia) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 05:31:36 GMT
• maia biotechnology inc (maia) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 05:04:16 GMT
• maia biotechnology inc (maia) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 04:37:01 GMT
• maia biotechnology inc (maia) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 04:12:28 GMT
• maia biotechnology inc (maia) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 04:11:02 GMT
• maia biotechnology inc (maia) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• maia biotechnology surges 4.6%, approaches key resistance at $1.43 - mesa ma newsline.com Tue, 16 Jun 2026 00:48:33 GMT
• maia biotechnology holds steady at $1.30, consolidating between support and resistance - etf creation redemption newsline.com Sun, 14 Jun 2026 16:38:45 GMT
• maia biotechnology (maia) holds steady at $1.30 as consolidation phase emerges - bullish percent index newsline.com Sat, 13 Jun 2026 18:44:14 GMT
• maia biotechnology q1 2026 earnings: narrower loss and pipeline progress signal operational discipline - pre-announcement alert newsline.com Sat, 13 Jun 2026 10:43:28 GMT
• MAIA Biotechnology opens second US site for THIO-101 trial Clinical Trials Arena Thu, 11 Jun 2026 07:00:00 GMT
• maia biotechnology activates second us site for phase 2 trial of lung cancer treatment Moomoo Wed, 10 Jun 2026 13:56:54 GMT
• MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial Yahoo Finance Wed, 10 Jun 2026 07:00:00 GMT
• MAIA's Lung Cancer Gambit: A Strategic Push into a $70B Market BriefGlance Wed, 10 Jun 2026 07:00:00 GMT
• maia biotechnology advances thio-101 expansion trial for non-small cell lung cancer with second u.s. clinical site activation Quiver Quantitative Wed, 10 Jun 2026 07:00:00 GMT
• maia q1 2026 earnings: eps beat on lower net loss, focus on clinical pipeline - consensus beat rate newsline.com Tue, 09 Jun 2026 17:33:36 GMT
• maia biotechnology q1 2026 earnings: narrower-than-expected loss amid clinical progress - eps consistency score newsline.com Sun, 07 Jun 2026 17:45:04 GMT
• FDA Clears IND Amendment for MAIA’s Ateganosine Phase 2 NSCLC Trial Expansion The Clinical Trial Vanguard Sat, 06 Jun 2026 07:00:00 GMT
• FDA Clears US Enrollment for Ateganosine Phase 2 NSCLC Trial Expansion Targeted Oncology Fri, 05 Jun 2026 07:00:00 GMT
• maia biotechnology inc. (maia) announced that its pivotal phase iii clinical trial for non-small cell lung cancer is showing stron... Bitget Thu, 04 Jun 2026 14:50:50 GMT
• maia biotechnology reports patient enrollment progress in phase 3 trial of telomere-targeting therapy for advanced non-small cell ... Quiver Quantitative Thu, 04 Jun 2026 13:50:00 GMT
• MAIA Biotechnology Reports Strong Enrollment and Dosing GlobeNewswire Thu, 04 Jun 2026 07:00:00 GMT
• Lung cancer trial drug saw 17.8-month survival vs 5.8 on chemo in MAIA study Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• maia biotechnology reports 29 patients dosed in phase 3 thio-104 trial TipRanks Thu, 04 Jun 2026 07:00:00 GMT
• maia biotechnology inc. (maia) announced that its pivotal phase iii clinical trial for non-small cell lung cancer is showing stron... Bitget Wed, 03 Jun 2026 22:51:36 GMT
• fda clears maia biotechnology to expand u.s. enrollment in phase 2 trial for lung cancer drug ateganosine Pluang Wed, 03 Jun 2026 14:34:22 GMT
• FDA clears U.S. trial of MAIA lung cancer drug for third-line patients Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• maia biotechnology receives fda clearance to open u.s. enrollment in ongoing phase 2 thio-101 trial expansion GlobeNewswire Wed, 03 Jun 2026 07:00:00 GMT
• maia biotechnology receives fda clearance for amendment to ind application TipRanks Wed, 03 Jun 2026 07:00:00 GMT
• top maia biotechnology insiders make bold moves with fresh stock purchases TipRanks Wed, 03 Jun 2026 05:14:28 GMT
• maia biotechnology ceo and director purchase company shares on open market geneonline.com Wed, 03 Jun 2026 03:42:45 GMT
• MAIA Biotechnology Announces Open Market Purchases by CEO and Director GlobeNewswire Tue, 02 Jun 2026 07:00:00 GMT
• Cancer-drug CEO, director buy MAIA stock at $1.3877 and $1.336 Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• MAIA Biotechnology Executives Increase Stock Holdings, Express Confidence in Cancer Immunotherapy Development Quiver Quantitative Tue, 02 Jun 2026 07:00:00 GMT
• Maia Biotechnology director Stan Smith buys $100,200 in company stock Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• Maia Biotechnology CSO Sergei Gryaznov buys $2,690 in common stock Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• Maia Biotechnology CEO Vlad Vitoc buys $100,885 in company stock Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• Director Stan Smith adds 75,000 MAIA (NASDAQ: MAIA) shares via trust purchase Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• MAIA (MAIA) Chief Scientific Officer purchases 2,000 company shares in market trade Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• maia biotechnology (maia) ceo vitoc vlad adds 72,700 shares in open-market buy Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• top maia biotechnology insiders make bold moves with fresh stock purchases TipRanks Tue, 02 Jun 2026 07:00:00 GMT
• MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 ... Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• MAIA Biotechnology (MAIA) grants CSO 400,000 stock options at $1.39 Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• MAIA Q1 2026 Earnings: Narrower-than-Expected Loss as Pre-Revenue Biotech Advances Pipeline - Consensus Beat Rate dars.gov.et Mon, 01 Jun 2026 07:00:00 GMT
• maia biotechnology (maia) grants 60,000 stock options to head of finance Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• maia (maia) ceo awarded 800,000 stock options at $1.39 exercise price Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• maia biotechnology cso sergei gryaznov buys $2,690 in common stock by investing.com Investing.com Nigeria Mon, 01 Jun 2026 07:00:00 GMT
• maia biotechnology presents phase 3 trial design for novel lung cancer drug at asco 2026 Pluang Mon, 01 Jun 2026 07:00:00 GMT
• maia biotechnology inc. (maia) surges 7.75%: potential breakout above key resistance? - ending diagonal newsline.com Fri, 29 May 2026 07:00:00 GMT
• maia biotechnology inc. (maia) gains 3.91% as biotech momentum lifts shares from support levels - regression channel The Legal Advocate Tue, 26 May 2026 22:41:14 GMT
• maia biotechnology q1 2026 earnings: narrower-than-expected loss highlights continued pipeline progress newsline.com Sat, 23 May 2026 07:00:00 GMT
• maia biotechnology, inc. 8-k filing: annual meeting results, company details, and nyse american listing Minichart Sat, 23 May 2026 07:00:00 GMT
• maia biotechnology, inc. 8-k filing: annual meeting results, company details, and nyse american listing Minichart Fri, 22 May 2026 18:33:00 GMT
• maia biotechnology (maia) investors back 2026 directors and auditor at meeting Stock Titan Fri, 22 May 2026 07:00:00 GMT
• maia biotechnology shareholders re-elect directors and ratify auditor at annual meeting Investing.com Fri, 22 May 2026 07:00:00 GMT
• maia biotechnology shareholders back board and auditor appointments TipRanks Fri, 22 May 2026 07:00:00 GMT
• maia biotechnology (maia) q1 2026 earnings surprise: eps $-0.14, up significant - earnings expansion phase newsline.com Tue, 19 May 2026 07:00:00 GMT
• should you sell maia biotechnology (maia) after -1.19% drop? 2026-05-19 - dealer delta newsline.com Tue, 19 May 2026 07:00:00 GMT
• diamond equity research releases update note on maia biotechnology, inc. (nyse: maia) Yahoo Finance Mon, 18 May 2026 07:00:00 GMT
• maia biotechnology (maia) flat at $1.26 — consolidation continues 2026-05-18 - volatility skew newsline.com Mon, 18 May 2026 07:00:00 GMT
• maia (nasdaq: maia) solas capital and f. t. golden report 7.1% ownership Stock Titan Fri, 15 May 2026 07:00:00 GMT
• maia biotechnology (maia) halts atm share sales and terminates program Stock Titan Thu, 14 May 2026 07:00:00 GMT
• maia (nyse american) terminates atm with h.c. wainwright after $5.68m raised Stock Titan Thu, 14 May 2026 07:00:00 GMT
• maia biotechnology to terminate atm agreement with h.c. wainwright after raising $5.68m TradingView Thu, 14 May 2026 07:00:00 GMT
• maia biotechnology - to terminate at the market offering agreement effective may 23, 2026 - sec filing TradingView Thu, 14 May 2026 07:00:00 GMT
• maia biotechnology, inc. 1q 2026: net income $(6.37m), eps $(0.14) — 10-q summary TradingView Mon, 11 May 2026 13:11:00 GMT
• maia biotechnology (maia) delivers q4 earnings beat, cutting losses by 32% as clinical pipeline advances. - earnings momentum scor... newsline.com Mon, 11 May 2026 07:00:00 GMT
• maia biotechnology (maia) boosts cash with $33m raise as nsclc trials advance Stock Titan Mon, 11 May 2026 07:00:00 GMT
• short interest in maia biotechnology, inc. (nyseamerican:maia) rises by 23.0% MarketBeat Sat, 02 May 2026 04:48:05 GMT
• maia biotechnology (maia) projected to post quarterly earnings on friday MarketBeat Fri, 01 May 2026 06:05:15 GMT
• maia biotechnology expects $33m capital raise to fund phase 3 trial of anticancer therapy MSN Tue, 28 Apr 2026 22:53:29 GMT
• maia biotechnology announces private placement of approximately $669,500 MSN Tue, 28 Apr 2026 14:07:07 GMT
• maia biotechnology announces private placement of approximately $669,500 MSN Mon, 27 Apr 2026 20:22:45 GMT
• maia biotechnology (maia) price target increased by 18.16% to 12.38 MSN Mon, 27 Apr 2026 13:27:10 GMT
• maia biotechnology expects $33m capital raise to fund phase 3 trial of anticancer therapy MSN Sun, 26 Apr 2026 10:01:46 GMT
• maia biotechnology (maia) price target increased by 18.16% to 12.38 MSN Sun, 26 Apr 2026 01:19:14 GMT
• maia biotechnology announces private placement of approximately $669,500 MSN Sat, 25 Apr 2026 13:33:30 GMT
• maia biotechnology (maia) price target increased by 18.16% to 12.38 MSN Sat, 25 Apr 2026 07:01:04 GMT
• maia biotechnology expects $33m capital raise to fund phase 3 trial of anticancer therapy MSN Sat, 25 Apr 2026 00:53:13 GMT
• maia biotechnology announces private placement of approximately $669,500 MSN Fri, 24 Apr 2026 05:17:54 GMT
• breaking: trump just bought this stock! (01ajqp9sss) fathomjournal.org Thu, 23 Apr 2026 18:15:50 GMT
• maia biotechnology (maia) posts narrower q4 2025 loss than analyst estimates, lifting shares 4.44 percent today. - community break... Xã Thanh Hà Thu, 23 Apr 2026 08:16:17 GMT
• maia biotechnology expects $33m capital raise to fund phase 3 trial of anticancer therapy MSN Wed, 22 Apr 2026 11:58:07 GMT
• maia biotechnology (maia) posts narrower q4 2025 loss than analyst estimates, lifting shares 4.44 percent today. - earnings qualit... The Legal Advocate Tue, 21 Apr 2026 07:00:00 GMT
• maia biotechnology expects $33m capital raise to fund phase 3 trial of anticancer therapy MSN Tue, 21 Apr 2026 00:19:37 GMT
• maia biotechnology expects $33m capital raise to fund phase 3 trial of anticancer therapy MSN Mon, 20 Apr 2026 14:24:20 GMT
• maia biotechnology (maia) stock ask wall (investor interest) 2026-04-20 - vol target rebalance newsline.com Mon, 20 Apr 2026 07:00:00 GMT
• maia biotechnology expects $33m capital raise to fund phase 3 trial of anticancer therapy MSN Sat, 18 Apr 2026 16:36:25 GMT
• maia biotechnology opens first u.s. site for lung cancer trial by investing.com Investing.com Australia Fri, 17 Apr 2026 19:23:58 GMT
• maia biotechnology (maia) price target increased by 18.16% to 12.38 MSN Fri, 17 Apr 2026 01:52:41 GMT
• maia biotechnology, inc. (nyseamerican:maia) short interest update MarketBeat Thu, 16 Apr 2026 17:42:37 GMT
• MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatme... Yahoo Finance Thu, 16 Apr 2026 07:00:00 GMT
• $2.3M NIH-backed lung cancer study opens first U.S. site Stock Titan Thu, 16 Apr 2026 07:00:00 GMT
• MAIA Biotechnology opens first U.S. site for lung cancer trial Investing.com Thu, 16 Apr 2026 07:00:00 GMT
• maia biotechnology (nyse: maia) opens first u.s. site in phase 2 nsclc trial Stock Titan Thu, 16 Apr 2026 07:00:00 GMT
MAIA Biotechnology, Inc.(NYSE MKT:MAIA) 
None
Share this website to your friends